Melanotan-II (MT-2) is a cyclic synthetic analog of alpha-melanocyte-stimulating hormone. Its proposed mechanism is broad agonism across the melanocortin-receptor family, making it a valuable reference for studying melanocortin signaling in research models.
Melanocortin-receptor agonism
MT-2 is a non-selective agonist of several melanocortin receptors, including MC1R (studied in relation to pigmentation research endpoints) and MC4R (studied in relation to central signaling research). The melanocortin receptors are G-protein-coupled receptors, and their activation is associated in model systems with adenylyl-cyclase stimulation and elevated intracellular cAMP.
Stability from cyclization
Its cyclic lactam structure improves stability relative to linear alpha-MSH, making MT-2 a durable research probe that maintains activity across assay conditions. This ties its chemistry directly to its usefulness as a mechanistic tool.
Contrast with a selective analog
MT-2's broad receptor activity contrasts with the more MC4R-focused profile studied for PT-141, a related melanocortin research peptide. Comparing a non-selective agonist against a subtype-focused one is a standard way to attribute observed effects to specific receptors. Sequence design follows general amino acid sequence principles, and its cyclic chemistry is best confirmed by HPLC vs. mass spectrometry.
Interpreting results
In-vitro concentrations are set by assay design, not human dosing, and receptor-level observations in models do not translate to physiological or cosmetic outcomes. Foundational context is in the Melanotan-II overview.
MC1R-linked model readouts
In pigmentation-oriented cell models, MC1R activation is associated with cAMP-dependent signaling and changes in melanogenic pathway markers. These are laboratory endpoints used to map receptor function. They should be reported as responses of the tested model, not as cosmetic or human-use outcomes, and receptor expression in the chosen cell system should be verified.
Dissecting subtype contributions
Because MT-2 is broad, an observed response cannot automatically be assigned to MC1R, MC3R, MC4R, or MC5R. Subtype-selective antagonists, engineered cell lines expressing one receptor, or genetic loss-of-function models can improve attribution. Comparing potency across matched assay systems is more informative than comparing values produced by different laboratories, readouts, or receptor-expression levels.
Assay controls
Appropriate negative controls should verify that the measured signal depends on receptor expression rather than nonspecific assay effects. Time courses and concentration-response experiments can further separate an early cAMP event from later transcriptional or pigment-related cellular changes.
Product page: Melanotan-II research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.